Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$32.50

-1.2 (-3.56%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25

Biohaven Pharmaceutical management to meet with Morgan Stanley

Group Luncheon Meeting with Chief Medical Officer Conway, where 1:1s will be available as well, will be held in Boston on November 15 hosted by Morgan Stanley.

  • 15

    Nov

  • 15

    Nov

  • 27

    Nov

BHVN Biohaven Pharmaceutical
$32.50

-1.2 (-3.56%)

11/12/18
OPCO
11/12/18
INITIATION
Target $63
OPCO
Outperform
Biohaven Pharmaceutical initiated with an Outperform at Oppenheimer
Oppenheimer analyst Esther Rajavelu started Biohaven Pharmaceutical with an Outperform rating and $63 price target. The stock offers "multiple value drivers" that are not reflected at current trading levels, Rajavelu tells investors in a research note. The analyst believes Biohaven's glutamate platform with two late stage assets is "under-the-radar."
11/12/18
LEER
11/12/18
INITIATION
Target $50
LEER
Outperform
Biohaven Pharmaceutical initiated with an Outperform at Leerink
Leerink Partners analyst Marc Goodman started Biohaven Pharmaceutical with an Outperform rating and $50 price target
11/13/18
LEER
11/13/18
INITIATION
Target $50
LEER
Outperform
Biohaven Pharmaceutical initiated with an Outperform at Leerink
Leerink analyst Marc Goodman started Biohaven Pharmaceutical with an Outperform and $50 price target as he initiates Neuroscience space with a Positive View. The analyst believes the Neuroscience sector is experiencing a "renaissance" as multiple new agents and mechanisms are coming up the pipeline across major therapeutic areas, the number of clinical studies is growing nicely, and the FDA is friendly to innovation in this space, companies are getting smarter about speed-to-market strategies and selecting niche sub-populations to focus on for initial product approvals, payer pushback on usage is much lower than in other categories, and physicians are enthusiastic about new agents. Regarding Biohaven Pharmaceutical, Goodman thinks the migraine space will be a significant market, the branded acute segment is underappreciated, and Biohaven will monetize the strong rimegepant clinical profile either with a "go it alone" strategy or most likely via a commercial partner.
11/14/18
PIPR
11/14/18
NO CHANGE
Target $65
PIPR
Overweight
Biohaven Pharmaceutical undervalued based on its catalysts, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren kept his Overweight rating and $65 price target on Biohaven Pharmaceutical, stating that its shares are undervalued in a "catalyst-rich year end". The analyst says the company's rimegepant long-term 52-week safety data is expected to be clean while its Phase 3 orally dissolving tablet version for the program could add a "layer of differentiation". Van Bure further points to the company's Phase 3 trial initiation in migraine prevention with an added opportunity for the "ongoing Phase 2/3 troriluzole Alzheimer's study in the middle of next year".

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/19/18
12/19
11:16
12/19/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$25.21

0.5 (2.02%)

11:10
12/19/18
12/19
11:10
12/19/18
11:10
Options
Call spreads in Nielsen as a bullish play is extended »

Call spreads in Nielsen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMITF

Elbit Imaging

$1.65

0.11 (7.14%)

11:04
12/19/18
12/19
11:04
12/19/18
11:04
Hot Stocks
Elbit Imaging says no longer controlling shareholder of Plaza Centers »

Elbit Imaging announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$21.53

0.46 (2.18%)

11:00
12/19/18
12/19
11:00
12/19/18
11:00
Options
Ratio put spread in Xerox as shares advance from 52-week lows »

Ratio put spread in Xerox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

10:55
12/19/18
12/19
10:55
12/19/18
10:55
General news
U.S. existing home sales were stronger than expected in November »

U.S. existing home sales…

COP

ConocoPhillips

$62.73

0.81 (1.31%)

10:50
12/19/18
12/19
10:50
12/19/18
10:50
Options
Notable call activity in ConocoPhillips »

Notable call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$123.49

5 (4.22%)

10:45
12/19/18
12/19
10:45
12/19/18
10:45
Downgrade
Mohawk rating change  »

Mohawk downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$158.32

3.66 (2.37%)

10:44
12/19/18
12/19
10:44
12/19/18
10:44
Hot Stocks
Route1 files patent infringement complaint against VMware, AirWatch »

Route1 announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

CI

Cigna

$192.93

0.83 (0.43%)

, ESRX

Express Scripts

$95.33

0.31 (0.33%)

10:44
12/19/18
12/19
10:44
12/19/18
10:44
Hot Stocks
Cigna, Express Scripts receive approval from state of NJ for merger transaction »

In a regulatory filing,…

CI

Cigna

$192.93

0.83 (0.43%)

ESRX

Express Scripts

$95.33

0.31 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

GM

General Motors

$35.68

0.77 (2.21%)

10:40
12/19/18
12/19
10:40
12/19/18
10:40
Options
Far upside call buyer in GM »

Far upside call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMD

Cantel Medical

$75.82

-0.35 (-0.46%)

10:37
12/19/18
12/19
10:37
12/19/18
10:37
Hot Stocks
Cantel Medical raises semiannual dividend 17.6% to 10c per share »

Cantel Medical Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$257.42

2.33 (0.91%)

10:32
12/19/18
12/19
10:32
12/19/18
10:32
Periodicals
Senate to introduce short-term measure to avoid government shutdown, CNBC says »

The Senate will introduce…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$257.42

2.33 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:31
12/19/18
12/19
10:31
12/19/18
10:31
General news
Crude inventories for week of December 14 »

Crude oil inventories…

ABX

Barrick Gold

$13.82

-0.07 (-0.50%)

10:30
12/19/18
12/19
10:30
12/19/18
10:30
Options
Heavy volume in Barrick Gold downside Jan puts »

Heavy volume in Barrick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$10.99

-0.05 (-0.45%)

10:29
12/19/18
12/19
10:29
12/19/18
10:29
Initiation
JinkoSolar initiated  »

JinkoSolar initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Dec

10:25
12/19/18
12/19
10:25
12/19/18
10:25
General news
Treasury Action: flattening is the trade ahead of the FOMC »

Treasury Action:…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

10:25
12/19/18
12/19
10:25
12/19/18
10:25
Conference/Events
UBS retail analyst to hold an analyst/industry conference call »

Retail Analyst Sole…

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
FX Action: The dollar »

FX Action: The dollar…

SPY

SPDR S&P 500 ETF Trust

$257.02

1.93 (0.76%)

10:20
12/19/18
12/19
10:20
12/19/18
10:20
Options
Size ratio spread in SPYders weekly options »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
12/19/18
12/19
10:20
12/19/18
10:20
General news
Treasury Action: yields remained pinned lower »

Treasury Action: yields…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

, MTCH

Match Group

$42.58

0.6 (1.43%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ULTA

Ulta Beauty

$245.00

4.07 (1.69%)

MTCH

Match Group

$42.58

0.6 (1.43%)

SSTI

ShotSpotter

$30.30

1.12 (3.84%)

OKTA

Okta

$66.09

3.32 (5.29%)

CLLS

Cellectis

$18.35

0.6 (3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 09

    Jan

  • 16

    Jan

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

, ADI

Analog Devices

$87.50

-0.57 (-0.65%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

ADI

Analog Devices

$87.50

-0.57 (-0.65%)

UAA

Under Armour

$18.63

-0.18 (-0.96%)

UA

Under Armour

$17.21

-0.18 (-1.04%)

MU

Micron

$33.30

-0.82 (-2.40%)

JPM

JPMorgan

$99.31

0.79 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 08

    Jan

  • 08

    Jan

  • 31

    Jan

  • 26

    Feb

  • 03

    Mar

MDT

Medtronic

$92.20

0.18 (0.20%)

, MASI

Masimo

$106.37

1.08 (1.03%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

MDT

Medtronic

$92.20

0.18 (0.20%)

MASI

Masimo

$106.37

1.08 (1.03%)

DRI

Darden

$103.74

-0.08 (-0.08%)

BBY

Best Buy

$52.56

0.57 (1.10%)

GE

General Electric

$7.78

0.505 (6.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/19/18
12/19
10:17
12/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.